Title:
CONTROLLED RELEASE FORMULATIONS
Document Type and Number:
WIPO Patent Application WO/2010/149169
Kind Code:
A3
Abstract:
The present invention relates to the field of controlled release formulations, and in particular to formulations useful for once daily administration. More particular, the present invention relates to compositions, which are formulated for continued administration to an individual in need thereof within the range of 20 to 28 hours interval between individual administrations.
More Like This:
Inventors:
ANDERSEN CHRISTINE (DK)
LINDHARDT KARSTEN (DK)
MARTIN OEVERGAARD JAN (DK)
INOKA LYHNE-IVERSEN LOUISE (DK)
REX OLSEN MARTIN (DK)
HAAHR ANNE-METTE (DK)
KRISTINE HOEYRUP HEMMINGSEN PERNILLE (DK)
LINDHARDT KARSTEN (DK)
MARTIN OEVERGAARD JAN (DK)
INOKA LYHNE-IVERSEN LOUISE (DK)
REX OLSEN MARTIN (DK)
HAAHR ANNE-METTE (DK)
KRISTINE HOEYRUP HEMMINGSEN PERNILLE (DK)
Application Number:
PCT/DK2010/050159
Publication Date:
June 16, 2011
Filing Date:
June 23, 2010
Export Citation:
Assignee:
EGALET AS (DK)
ANDERSEN CHRISTINE (DK)
LINDHARDT KARSTEN (DK)
MARTIN OEVERGAARD JAN (DK)
INOKA LYHNE-IVERSEN LOUISE (DK)
REX OLSEN MARTIN (DK)
HAAHR ANNE-METTE (DK)
KRISTINE HOEYRUP HEMMINGSEN PERNILLE (DK)
ANDERSEN CHRISTINE (DK)
LINDHARDT KARSTEN (DK)
MARTIN OEVERGAARD JAN (DK)
INOKA LYHNE-IVERSEN LOUISE (DK)
REX OLSEN MARTIN (DK)
HAAHR ANNE-METTE (DK)
KRISTINE HOEYRUP HEMMINGSEN PERNILLE (DK)
International Classes:
A61K9/20
Domestic Patent References:
WO2008148798A2 | 2008-12-11 | |||
WO2008086804A2 | 2008-07-24 |
Foreign References:
EP1213014A2 | 2002-06-12 |
Other References:
L. QIU ET AL.: "Design of a core-shelled polymer cylinder for potential programmable drug delivery", INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 219, 2001, pages 151 - 160, XP002567272
Attorney, Agent or Firm:
HØIBERG A/S (Copenhagen K, DK)
Download PDF:
Previous Patent: EXPANDABLE DIFFUSER
Next Patent: TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE
Next Patent: TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE